Arcutis Biotherapeutics, Inc. Common Stock vs. Johnson & Johnson
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
$32.07 +0.31%
VS JNJJohnson & Johnson
$283.11 +0.96%
Arcutis Biotherapeutics, Inc. Common Stock and Johnson & Johnson are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ARQT | JNJ | |
|---|---|---|
| Market Cap | $4.03 billion | $675.03 billion |
JNJ leads on 1 of 1 size & scale factors.
Dividend
| ARQT | JNJ | |
|---|---|---|
| Dividend Yield | — | 1.89% |
ARQT and JNJ split the dividend factors evenly.
Risk & Sentiment
| ARQT | JNJ | |
|---|---|---|
| Short Interest | 0.19% | 0.67% |
ARQT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ARQT overview, ARQT financials, JNJ overview, JNJ financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.